Effects of homocysteine on number and activity of endothelial progenitor cells from peripheral blood

Journal of Molecular and Cellular Cardiology

Volumn 36, Issue 2, 2004, Pages 233-239

  Chen, J Z ^a   Zhu, J H ^a   Wang, X X ^a   Xie, X D ^a   Sun, J ^a   Shang, Y P ^a   Guo, X G ^a   Dai, H M ^a   Hu, S J ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Coronary artery disease; Endothelial dysfunction; Endothelial progenitor cell; Homocysteine; Laser scanning confocal microscope

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; FICOLL; FLUORESCENT DYE; HOMOCYSTEINE; LECTIN;

ADHERENT CELL; ANGIOGENESIS; ARTICLE; BLOOD; CELL ACTIVITY; CELL ADHESION; CELL ASSAY; CELL COUNT; CELL DENSITY; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CENTRIFUGATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LASER MICROSCOPE; LECTIN BINDING; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; STAINING; STEM CELL;

EID: 10744230139     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2003.10.005     Document Type: Article

References (23)

1. Nygard O., Nordrehaug J.E., Refsum H. Plasmahomocysteine levels and mortality in patients with coronary artery disease. New Engl J Med. 337:1997;230-236.
2. Woo K.S., Chook P., Lolin Y.I., Cheung A.S., Chan L.T., Sun Y.Y., et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation. 96:1997;2542-2544.
3. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med. 348:2003;593-600.
4. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerate reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation. 105:2002;3017-3024.
5. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T. Isolation of putative endothelial progenitor cells for angiogenesis. Science. 275:1997;964-967.
6. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 95:2000;952-958.
7. Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., et al. Transplanted cord blood-derived endothelial progenitor cells augment postnatal neovascularization. J Clin Invest. 105:2000;1527-1536.
8. Kocher A.A., Schuster M.D., Szabolcs M.J., Takuma S., Burkhoff D., Wang J., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 7:2001;430-436.
9. Grant M.B., May W.S., Caballero S., Brown G.A., Guthrie S.M., Mames R.N., et al. Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 8:2002;607-612.
10. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 89:2001;E1-E7.
11. Kalka C., Masuda H., Takahashi T., Kalka-Moll W.M., Silver M., Kearney M., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA. 97:2000;3422-3427.
12. Shipchandler M.T., Moore E.G. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem. 41:1995;991-994.
13. Tepper O.M., Galiano D.R., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation. 106:2002;2781-2786.
14. Reyes M., Dudek A., Jahagirdar B., Koodie L., Marker P.H., Verfaillie C.M. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest. 109:2002;337-346.
15. Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 85:1999;221-228.
16. Clarke R., Daly L., Robinson K., Naughten E., Cahalane S., Fowler B., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. New Engl J Med. 324:1991;1149-1155.
17. Stampfer M.I., Malinow M.R. Can lowering homocyst(e)ine levels reduce cardiovascular risk? New Engl J Med. 332:1995;328-329.
18. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. New Engl J Med. 338:1998;1042-1050.
19. McCully K.S. Homocysteine and vascular disease. Nat Med. 2:1996;386-389.
20. Woo K.S., Qiao M., Chook P., Poon P.Y., Chan A.K., Lau J.T., et al. Homocysteine, endothelial dysfunction, and coronary artery disease: emerging strategy for secondary prevention. J Card Surg. 17:2002;432-435.
21. Rafii S. Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest. 105:2000;17-19.
22. Murayama T., Tepper O.M., Silver M., Ma H., Losordo D.W., Isner J.M., et al. Determination of bone marrow-derived endothelial progenitor cell significance in angiogenic growth factor-induced neovascularization. Exp Hematol. 30:2002;967-972.
23. Suzuki T., Nishida M., Futami S., Fukino K., Amaki T., Aizawa K., et al. Neoendothelialization after peripheral blood stem cell transplantation in humans. A case report of a Tokaimura nuclear accident victim. Cardiovasc Res. 58:2003;487-492.